JACKQUELYN WILLIAMS: Open Payments
NPI 1306249602 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $489 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $118 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Corium, LLC | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| LivaNova USA, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
Products named: CAPLYTA, INGREZZA, Azstarys, Auvelity, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, ARISTADA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
